Sri Sathya Sai Institute of Higher Learning (SSSIHL) is pleased to announce the signing of a strategic Memorandum of Understanding (MoU) with Virchow Biotech Pvt. Ltd., a leading biopharmaceutical company known for its global presence in the healthcare sector.
This collaboration aims to build a strong bridge between academia and industry in the domains of biosciences, biotechnology, and translational research, with an emphasis on real-world applications, student development, and societal impact.
Key Areas of Collaboration:
- Industry-Sponsored Student Training & Research: Hands-on industrial exposure and skill development through Virchow Foundation initiatives.
- Collaborative Research Projects: Joint research in cutting-edge areas of biosciences and biotechnology.
- Sponsored PhD Programs: Industry-supported fellowships to empower future research leaders.
- Shared Research Infrastructure: Access to SSSIHL’s advanced Central Research Instruments Facility (CRIF) for joint R&D.
- Technology Development & Commercialization: Support for translating research outcomes into real-world innovations.
- Student Recruitment: Enhancing career opportunities for students through active placement support.
The MoU was signed on 13 June 2025 at Virchow Biotech Pvt. Ltd. between Dr. Srikanth Khanna, Registrar, SSSIHL and Dr. Murali Tummuru, Managing Director of Virchow Biotech Pvt. Ltd.
The event was graced by:
- Prof. B. Raghavendra Prasad – Vice Chancellor, SSSIHL
- Prof. Pallav Kumar Baruah– Dean of Innovation & Entrepreneurship and President, Institution’s Innovation Council, SSSIHL
- Dr. B. E. Pradeep– Department of Biosciences, SSSIHL
- Prof. Pallu Reddanna, Executive President, FABA, whose continued guidance and encouragement have been instrumental in advancing academia-industry engagement in the life sciences sector.
This partnership marks a significant step in SSSIHL’s mission to foster values-based research, innovation, and entrepreneurship that meaningfully contributes to both scientific progress and societal welfare.
